Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07521735 · ClinicalTrials.gov registry record
Next GEN - Philips Optimus
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 36
- Enrollment target
NCT07521735 is a clinical trial that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 36 participants.
The verdict
NCT07521735 is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.
Interventions
- DEVICE Philips MR400 Pro MRI Patient Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-03-09 |
| Est. Completion | 2026-04-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07521735
The ClinicalTrials.gov registry entry for NCT07521735 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Philips MR400 Pro MRI Patient Monitor is the first listed.
NCT07521735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07521735 about?
NCT07521735 is a clinical study titled "Next GEN - Philips Optimus". The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.
What is the current status of trial NCT07521735?
This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2026-03-09. Estimated completion is 2026-04-03.
What interventions are being tested in trial NCT07521735?
The interventions under investigation include: Philips MR400 Pro MRI Patient Monitor (DEVICE).
Who is sponsoring clinical trial NCT07521735?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.